Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

xCELLigence Useful for Testing Cytotoxicity

May 3, 2010 7:54 am | Product Releases | Comments

Monitoring of cell viability and toxicity are critical to many areas of biological and biomedical research. This is true for understanding the molecular and biochemical pathways regulating cell viability, for developing therapeutic agents which modulate cell viability and for identifying potential cytotoxic side effects of potential therapeutic agents.


Indiana Researchers Find Inflammatory Trigger

May 3, 2010 7:43 am | News | Comments

Researchers at Indiana University School of Medicine have identified a mechanism that causes inflammation in asthma and other allergic diseases, a discovery that could lead to new targets to control such allergic reactions.


CFSE T Cell Proliferation Assays

May 3, 2010 7:17 am | Product Releases | Comments

ProImmune Ltd offers the CFSE T cell proliferation assays for immunogenicity risk assessment used in the design and selection of biological drug leads at the preclinical stage.


BrainCells Issued First Patent for Neurogenic Drug Combinations

May 3, 2010 7:08 am | News | Comments

BrainCells Inc. announced that the United States Patent and Trademark Office issued the company Patent Number 7,678,808 entitled, “5 HT Receptor Mediated Neurogenesis.”


TB Alliance Collaborating With AstraZeneca

May 3, 2010 7:02 am | News | Comments

The Global Alliance for TB Drug Development (TB Alliance) and AstraZeneca announced at the 2010 BIO International Convention that they have entered into a research collaboration agreement to accelerate the discovery, development and clinical use of drugs against tuberculosis (TB), including drug-resistant strains of the disease.


Advanced Mycoplasma Tests

May 3, 2010 7:02 am | Product Releases | Comments

A new white paper, “Advanced Detection of Mycoplasmas: How Real-Time PCR Analysis Helps Save Time and Money for Biopharmaceutical Manufacturers,” explores relevant mycoplasma characteristics, established testing solutions, and the use of real-time PCR analysis as an alternative testing method for fast, preliminary mycoplasma detection.


Anti-Bacteria Antibodies

May 3, 2010 6:59 am | Drug Discovery & Development | Product Releases | Comments

BacTrace antibodies to infectious disease agents include Borrelia burgdorferi, Borrelia species, Legionella species and Helicobacter pylori.


Radix BioSolutions Adopts Gyrolab xP Workstation

May 3, 2010 6:54 am | News | Comments

Radix BioSolutions will integrate a Gyrolab xP workstation into its immunoassay development programs.


Single-channel Microplate Reader

May 3, 2010 6:51 am | Product Releases | Comments

The Biochrom Asys UVM340 monochromator-based plate reader lets users select the exact wavelength to measure optical density for an application.


Children With Autism Frequently Receive Psychotropic Medications

May 3, 2010 6:49 am | News | Comments

Behavioral interventions typically are the first line of treatment to manage unwanted behaviors in children with autism spectrum disorders (ASDs). If behaviors do not improve, medications frequently are added to the mix.


HAMA Blocker

May 3, 2010 6:45 am | Product Releases | Comments

amsbio has introduced TRU Block, a highly potent reagent that actively blocks the heterophilic antibody (HA) interference in immunoassays including Human Anti-Mouse Antibody (HAMA) interference.


Gene Mutations Linked to Autism

May 3, 2010 6:44 am | News | Comments

Although there is no known cause of autism, studies have shown that mutations in several genes are associated with the developmental brain disorder. New research has uncovered two additional genes that may be involved with autism.


Automated Cell-Based ELISA Procedures

May 3, 2010 6:42 am | Product Releases | Comments

Agilent Automation Solutions has configured its BioCel System that to allow laboratories to fully automate cell-based ELISA procedures thereby reducing the risk of human error, contamination, and time spent on tedious manual procedures.


Junk DNA Drives Cancer Growth

May 3, 2010 6:39 am | News | Comments

Researchers from the University of Leeds, UK, the Charité University Medical School and the Max Delbrück Centre for Molecular Medicine (MDC) in Berlin, Germany, have discovered a new driving force behind cancer growth.


FDA Approves sNDA for CREON

May 3, 2010 6:34 am | News | Comments

Abbott announced that the U.S. Food and Drug Administration approved the supplemental New Drug Application for CREON delayed-release capsules.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.